What you need to know – Symphony Natural Health

References

1. Jabeen A, Yamini V, Rahman Amberina A, Dinesh Eshwar M, Vadakedath S, Begum GS, et al. Polycystic Ovarian Syndrome: Prevalence, Predisposing Factors, and Awareness Among Adolescent and Young Girls of South India. Cureus. 2022;

2. Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. Vol. 13, Journal of Human Reproductive Sciences. 2020.

3. Copp T, Muscat DM, Hersch J, McCaffery KJ, Doust J, Mol BW, et al. Clinicians’ perspectives on diagnosing polycystic ovary syndrome in Australia: A qualitative study. Human Reproduction. 2020;35(3).

4. Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. Vol. 102, Journal of Clinical Endocrinology and Metabolism. 2017.

5. Gibson-Helm ME, Lucas IM, Boyle JA, Teedea HJ. Women’s experiences of polycystic ovary syndrome diagnosis. Fam Pract. 2014;31(5).

6. Smet ME, McLennan A. Rotterdam criteria, the end. Australas J Ultrasound Med. 2018;21(2).

7. Christ JP, Cedars MI. Current Guidelines for Diagnosing PCOS. Vol. 13, Diagnostics. 2023.

8. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Vol. 106, Fertility and Sterility. 2016.

9. Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Vol. 37, Endocrine Reviews. 2016.

10. Szukiewicz D, Trojanowski S, Kociszewska A, Szewczyk G. Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic Factors. Vol. 23, International Journal of Molecular Sciences. 2022.

11. Yesiladali M, Yazici MGK, Attar E, Kelestimur F. Differentiating Polycystic Ovary Syndrome from Adrenal Disorders. Diagnostics. 2022 Aug 24;12(9):2045.

12. Dhariwala MY, Ravikumar P. An overview of herbal alternatives in androgenetic alopecia. Vol. 18, Journal of Cosmetic Dermatology. 2019.

13. Zeng LH, Rana S, Hussain L, Asif M, Mehmood MH, Imran I, et al. Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies. Vol. 13, Frontiers in Pharmacology. 2022.

14. Meissner, HO Mscisz, A Bilinska-Reich, H, Kapczynski, W, Mrozikiewicz, P Bobkiewicz-Kozlowska, T Kedzia, B Lowicka, A Barchia I. Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double Blind, Randomized, Placebo-Controlled, Multi-Centre C. Int J Biomed Sci. 2006;2(4):360–74.

15. Meissner HO, Kapczynski W, Mscisz A, Lutomski J. Use of gelatinized maca (lepidium peruvianum) in early postmenopausal women. Int J Biomed Sci. 2005;

16. Meissner HO, Reich-Bilinska H, Mscisz A, Kedzia B. Therapeutic Effects of Pre-Gelatinized Maca (Lepidium Peruvianum Chacon) used as a Non-Hormonal Alternative to HRT in Perimenopausal Women – Clinical Pilot Study. Int J Biomed Sci. 2006;

17. Meissner HO, Mscisz A, Reich-Bilinska H, Mrozikiewicz P, Bobkiewicz-Kozlowska T, Kedzia B, et al. Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind, randomized, Placebo-controlled, crossover configuration, outpatient study. Int J Biomed Sci. 2006;

18. Srikugan L, Sankaralingam A, McGowan B. First case report of testosterone assay-interference in a female taking maca (Lepidium meyenii). Case Reports. 2011 Mar 25;2011(mar24 1):bcr0120113781–bcr0120113781.

19. Che X, Chen Z, Liu M, Mo Z. Dietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome. Vol. 77, Annals of Nutrition and Metabolism. 2021.

20. Di Lorenzo M, Cacciapuoti N, Lonardo MS, Nasti G, Gautiero C, Belfiore A, et al. Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review. Current Nutrition Reports. 2023.

21. Shang Y, Zhou H, He R, Lu W. Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Vol. 12, Frontiers in Endocrinology. 2021.

22. Xenou M, Gourounti K. Dietary Patterns and Polycystic Ovary Syndrome: a Systematic Review. Maedica – A Journal of Clinical Medicine. 2021;16(3).

23. Hendel B. Water And Salt-The Essence Of Life. Stenhouse Publishers; 2007.

24. Almenning I, Rieber-Mohn A, Lundgren KM, Løvvik TS, Garnæs KK, Moholdt T. Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: A pilot study. PLoS One. 2015;10(9).

25. Ryan BJ, Schleh MW, Ahn C, Ludzki AC, Gillen JB, Varshney P, et al. Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese Adults. Journal of Clinical Endocrinology and Metabolism. 2020;105(8).

26. Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome. Vol. 5, Journal of Functional Morphology and Kinesiology. 2020.

27. Kite C, Parkes E, Taylor SR, Davies RW, Lagojda L, Brown JE, et al. Time to Load Up–Resistance Training Can Improve the Health of Women with Polycystic Ovary Syndrome (PCOS): A Scoping Review. Medical Sciences. 2022;10(4).

28. Moran LJ, March WA, Whitrow MJ, Giles LC, Davies MJ, Moore VM. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. Human Reproduction. 2015;30(2).

29. Luo J, Jiang W. A critical review on clinical evidence of the efficacy of lavender in sleep disorders. Phytotherapy Research. 2022 Jun 12;36(6):2342–51.

30. Ali R, Tariq S, Kareem O, Fayaz F, Aziz T, Meenu, et al. Nutraceuticals for Sleep Disorders. Comb Chem High Throughput Screen. 2021 Sep 14;24(10):1583–92.

31. Türközü D, Şanlier N. L-theanine, unique amino acid of tea, and its metabolism, health effects, and safety. Crit Rev Food Sci Nutr. 2017 May 24;57(8):1681–7.

32. Minich DM, Henning M, Darley C, Fahoum M, Schuler CB, Frame J. Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements. Nutrients [Internet]. 2022;14(19). Available from: https://www.mdpi.com/2072-6643/14/19/3934/htm

33. Srnovršnik T, Virant-Klun I, Pinter B. Polycystic Ovary Syndrome and Endocrine Disruptors (Bisphenols, Parabens, and Triclosan)—A Systematic Review. Vol. 13, Life. 2023.

34. Hackett ES, Twedt DC, Gustafson DL. Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease. J Vet Intern Med. 2013 Jan;27(1):10–6.

35. Ali Esmail Al-Snafi, Hanaa Salman Khadem, Hussein Ali Al-Saedy, Ali M. Alqahtani, Gaber El-Saber Batiha, Jafari-Sales Abolfazl. A review on Medicago sativa: A potential medicinal plant. International Journal of Biological and Pharmaceutical Sciences Archive. 2021 Feb 28;1(2):022–33.

36. Legro RS, Chen G, Kunselman AR, Schlaff WD, Diamond MP, Coutifaris C, et al. Smoking in infertile women with polycystic ovary syndrome: Baseline validation of self-report and effects on phenotype. Human Reproduction. 2014;29(12).